Consensus ‘Interferon therapy for patients with influenza, SARS and COVID19’

According to the who, share of acute respiratory viral infections (амма? and influenza) accounts for about 90–95% all infectious diseases; in russia, influenza arvi take up 40% total duration official disability, which determines significance this pathology. At same time, primary contact overwhelming majority patients with suspected occurs a therapist or general practitioner polyclinics. The proposed consensus experts is intended systematize known approaches diagnosis, treatment secondary prevention influenza, community-acquired pneumonia their use at outpatient clinics. schemes using interferon therapy are considered detail.